On How Increasing Numbers of Newer Cancer Therapies Further Delay Referral to Hospice: The Increasing Palliative Care Imperative

Abstract

Delay in referral of cancer patients to hospice until very near the end of life may deny patients and families optimal palliative care. A variety of factors may contribute to these delays. This article describes how the proliferation of newer anticancer therapies, although desirable overall, may further increase these delays. It is important for hospice personnel to understand these changes in medical oncology and to work to optimize palliative care delivery concomitantly with disease-remitting therapies.

Keywords

hospice palliative care chemotherapy

Get full access to this article

View all access options for this article.

References

McCarthy EP , Burns RB , Davis RB , Phillips RS Barriers to hospice care among older patients dying with lung and colorectal cancer. J Clin Oncol. 2003;21:728-735.

Earle CC , Neville BA , Landrum MB , Ayanian JZ , Block SD , Weeks JC Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004; 22: 315-21.

Earle CC , Landrum M. , Jeffrey S. , Neville B. , Weeks J. , Ayanian J. Consistency in regional trends of aggressiveness in cancer care near the end of life for elderly Americans 1991-2000. Proc ASCO. 2006;302S.

National Hospice and Palliative Care Organization. 2004 Facts and Figures. Available at: www.nhpco.org. Accessed Nov 27, 2006.

Shepherd FA , Dancey J. , Ramlau R. , et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol. 2000; 8:2095-2103.

Hanna N. , Shepherd FA , Fossella FV , et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small cell lung cancer previously treated with chemotherapy . J Clin Oncol. 2004;22:1589-1597.

Shepherd FA , Rodrigues Pereira J , Ciuleanu T. , et al. Erlotinib in previously treated non-small cell lung cancer. New Engl J Med. 2005;353:123-132.

Pfister DG , Johnson DH , Azzoli CG , eg al. American Society of Clinical Oncology Treatment of unresectable non small-cell lung cancer guideline: update 2003. J Clin Oncol. 2004;22:330-353.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines In Oncology: Non-Small Cell Lung Cancer . Availabale at: www.nccn.org. Accessed Nov 27, 2006.

10.

Neuss MN , Jacobson JO , Earle C. , et al. Evaluating end of life care: the Quality Oncology Practice Initiative (QOPI) experience. Proc ASCO. 2006;486S.

11.

Zimmermann C. , Wennberg R. Integrating palliative care: a post-modern perspective. Am J Hosp Palliat Care. 2006;23:255-258.

12.

Casarett D. , Abrahm JL Patients with cancer referred to hospice versus a bridge program: patient characteristics, needs for care and survival. J Clin Oncol. 2001;19:2057-2063.